Literature DB >> 3510855

Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats.

J Terrettaz, F Assimacopoulos-Jeannet, B Jeanrenaud.   

Abstract

The action of insulin on glucose metabolism and hepatic glucose production was studied in vivo over a wide range of insulin concentrations in lean and genetically obese (fa/fa) rats, using the euglycemic clamp technique. While total glucose metabolism was stimulated 3-fold by insulin in lean animals (half-maximal stimulation at 400 microU/ml insulin), the hormone had no significant effect on glucose metabolism in obese animals, whatever the concentration used. In lean rats, the endogenous (i.e. hepatic) glucose production was completely suppressed at a steady state insulin concentration of about 360 microU/ml. In obese rats, an insulin concentration as high as 10,000 microU/ml was needed to suppress the hepatic glucose production. These results suggest that, in obese rats 1) basal plasma insulin levels appear to maximally stimulate peripheral glucose metabolism, and the presence of postreceptor defects prevents any further stimulatory effect of the hormone on glucose metabolism; 2) grave impairments of the action of insulin on hepatic glucose production are present, despite a normal responsiveness obtained at pharmacological concentrations of the hormone. These hepatic alterations could be due to postbinding and/or intracellular defects, as well as to defects, yet to be defined, of the homeostasis of insulin counterregulatory hormones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510855     DOI: 10.1210/endo-118-2-674

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Mechanism for increased insulin-stimulated glucose metabolism in adipocytes from 13-week-old obese Zucker rats.

Authors:  O Ezaki
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

2.  Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Authors:  N Deblon; L Bourgoin; C Veyrat-Durebex; M Peyrou; M Vinciguerra; A Caillon; C Maeder; M Fournier; X Montet; F Rohner-Jeanrenaud; M Foti
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  The onset of liver glycogen synthesis in fasted-refed lean and genetically obese (fa/fa) rats.

Authors:  G van de Werve; B Jeanrenaud
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.

Authors:  Christine Ahlström; Tobias Kroon; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-10-10       Impact factor: 2.745

5.  Amino acid metabolism in several tissues of the obese Zucker rat as indicated by the tissue accumulation of alpha-amino[1-14C]isobutyrate.

Authors:  M Domènech; F J López-Soriano; N Carbó; J M Argilés
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

Review 6.  An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

7.  Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.

Authors:  B Dorfmeister; S Brandlhofer; F G Schaap; M Hermann; C Fürnsinn; B P Hagerty; H Stangl; W Patsch; W Strobl
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

8.  Direct effects of leptin on brown and white adipose tissue.

Authors:  C A Siegrist-Kaiser; V Pauli; C E Juge-Aubry; O Boss; A Pernin; W W Chin; I Cusin; F Rohner-Jeanrenaud; A G Burger; J Zapf; C A Meier
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

9.  Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion.

Authors:  P Cettour-Rose; C Theander-Carrillo; C Asensio; M Klein; T J Visser; A G Burger; C A Meier; F Rohner-Jeanrenaud
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

10.  Decrease in serum matrix metalloproteinase-9 and matrix metalloproteinase-3 levels in Zucker fa/fa obese rats after treatment with swertiamarin.

Authors:  Hb Vaidya; S Giri; M Jain; Rk Goyal
Journal:  Exp Clin Cardiol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.